List of Excipients in API ESCITALOPRAM OXALATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ESCITALOPRAM OXALATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | CELLULOSE, MICROCRYSTALLINE | |
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | CROSCARMELLOSE SODIUM | |
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | HYPROMELLOSES | |
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | MAGNESIUM STEARATE | |
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | POLYETHYLENE GLYCOLS | |
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | SILICON DIOXIDE | |
| STAT Rx USA LLC | LEXAPRO | escitalopram oxalate | 16590-833 | TALC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ESCITALOPRAM OXALATE
Detailed excipient profiles for ESCITALOPRAM OXALATE
Excipient focus: ANHYDROUS CITRIC ACID
ESCITALOPRAM OXALATE drug variants containing ANHYDROUS CITRIC ACID
ESCITALOPRAM OXALATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BUTYLATED HYDROXYANISOLE
ESCITALOPRAM OXALATE drug variants containing BUTYLATED HYDROXYANISOLE
ESCITALOPRAM OXALATE drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: BUTYLATED HYDROXYTOLUENE
ESCITALOPRAM OXALATE drug variants containing BUTYLATED HYDROXYTOLUENE
ESCITALOPRAM OXALATE drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
ESCITALOPRAM OXALATE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | escitalopram oxalate | 33342-036 |
| A-S Medication Solutions | escitalopram oxalate | 50090-7200 |
| A-S Medication Solutions | escitalopram oxalate | 50090-7201 |
| NorthStar RxLLC | escitalopram oxalate | 72603-149 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ESCITALOPRAM OXALATE drug variants containing CELLULOSE, MICROCRYSTALLINE
ESCITALOPRAM OXALATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
ESCITALOPRAM OXALATE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | escitalopram oxalate | 51672-1348 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
ESCITALOPRAM OXALATE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| DIRECT RX | escitalopram oxalate | 61919-028 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
ESCITALOPRAM OXALATE drug variants containing CROSCARMELLOSE SODIUM
ESCITALOPRAM OXALATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: GLYCERIN
ESCITALOPRAM OXALATE drug variants containing GLYCERIN
ESCITALOPRAM OXALATE drug variants not containing GLYCERIN
Excipient focus: HYDROXYPROPYL CELLULOSE
ESCITALOPRAM OXALATE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | escitalopram oxalate | 50436-0054 |
| Graviti Pharmaceuticals Private Limited | escitalopram oxalate | 69844-033 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
ESCITALOPRAM OXALATE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | escitalopram oxalate | 50436-0054 |
| Bryant Ranch Prepack | escitalopram oxalate | 63629-2981 |
| BluePoint Laboratories | escitalopram oxalate | 68001-195 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
ESCITALOPRAM OXALATE drug variants containing HYPROMELLOSE 2910
ESCITALOPRAM OXALATE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
ESCITALOPRAM OXALATE drug variants containing HYPROMELLOSES
ESCITALOPRAM OXALATE drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
ESCITALOPRAM OXALATE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | escitalopram oxalate | 33342-036 |
| A-S Medication Solutions | escitalopram oxalate | 50090-7200 |
| A-S Medication Solutions | escitalopram oxalate | 50090-7201 |
| NorthStar RxLLC | escitalopram oxalate | 72603-149 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
ESCITALOPRAM OXALATE drug variants containing LACTOSE MONOHYDRATE
ESCITALOPRAM OXALATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
ESCITALOPRAM OXALATE drug variants containing MAGNESIUM STEARATE
ESCITALOPRAM OXALATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALIC ACID
ESCITALOPRAM OXALATE drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | escitalopram oxalate | 16571-769 |
| Camber Pharmaceuticals Inc | escitalopram oxalate | 31722-569 |
| Taro Pharmaceuticals USA Inc | escitalopram oxalate | 51672-1348 |
| Aurobindo Pharma Limited | escitalopram oxalate | 65862-248 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing MALIC ACID
Excipient focus: METHYLPARABEN
ESCITALOPRAM OXALATE drug variants containing METHYLPARABEN
ESCITALOPRAM OXALATE drug variants not containing METHYLPARABEN
Excipient focus: PEPPERMINT
ESCITALOPRAM OXALATE drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | escitalopram oxalate | 16571-769 |
| Camber Pharmaceuticals Inc | escitalopram oxalate | 31722-569 |
| Aurobindo Pharma Limited | escitalopram oxalate | 65862-248 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing PEPPERMINT
Excipient focus: POLYETHYLENE GLYCOL
ESCITALOPRAM OXALATE drug variants containing POLYETHYLENE GLYCOL
ESCITALOPRAM OXALATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
ESCITALOPRAM OXALATE drug variants containing POLYETHYLENE GLYCOL 400
ESCITALOPRAM OXALATE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOLS
ESCITALOPRAM OXALATE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | escitalopram oxalate | 16590-833 |
| Aidarex Pharmaceuticals LLC | escitalopram oxalate | 33261-699 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POVIDONE
ESCITALOPRAM OXALATE drug variants containing POVIDONE
ESCITALOPRAM OXALATE drug variants not containing POVIDONE
Excipient focus: POVIDONE K12
ESCITALOPRAM OXALATE drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | escitalopram oxalate | 0904-6426 |
| A-S Medication Solutions | escitalopram oxalate | 50090-2752 |
| Cardinal Health 107 LLC | escitalopram oxalate | 55154-6893 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing POVIDONE K12
Excipient focus: POVIDONES
ESCITALOPRAM OXALATE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | escitalopram oxalate | 10544-224 |
| Aidarex Pharmaceuticals LLC | escitalopram oxalate | 33261-955 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing POVIDONES
Excipient focus: PROPYL GALLATE
ESCITALOPRAM OXALATE drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | escitalopram oxalate | 33342-036 |
| A-S Medication Solutions | escitalopram oxalate | 50090-7200 |
| A-S Medication Solutions | escitalopram oxalate | 50090-7201 |
| NorthStar RxLLC | escitalopram oxalate | 72603-149 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing PROPYL GALLATE
Excipient focus: PROPYLENE GLYCOL
ESCITALOPRAM OXALATE drug variants containing PROPYLENE GLYCOL
ESCITALOPRAM OXALATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
ESCITALOPRAM OXALATE drug variants containing PROPYLPARABEN
ESCITALOPRAM OXALATE drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
ESCITALOPRAM OXALATE drug variants containing SILICON DIOXIDE
ESCITALOPRAM OXALATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
ESCITALOPRAM OXALATE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | escitalopram oxalate | 0121-0852 |
| ATLANTIC BIOLOGICALS CORP | escitalopram oxalate | 17856-0551 |
| Taro Pharmaceuticals USA Inc | escitalopram oxalate | 51672-1348 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing SODIUM CITRATE
Excipient focus: SORBITOL
ESCITALOPRAM OXALATE drug variants containing SORBITOL
ESCITALOPRAM OXALATE drug variants not containing SORBITOL
Excipient focus: TALC
ESCITALOPRAM OXALATE drug variants containing TALC
ESCITALOPRAM OXALATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ESCITALOPRAM OXALATE drug variants containing TITANIUM DIOXIDE
ESCITALOPRAM OXALATE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
ESCITALOPRAM OXALATE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | escitalopram oxalate | 16571-769 |
| Camber Pharmaceuticals Inc | escitalopram oxalate | 31722-569 |
| Aurobindo Pharma Limited | escitalopram oxalate | 65862-248 |
| >Company | >Ingredient | >NDC |
ESCITALOPRAM OXALATE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
ESCITALOPRAM OXALATE drug variants containing WATER
ESCITALOPRAM OXALATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
